Učinkovitost in vivo detoksifikacije ohratoksina A pomoću visokoporoznog nanokompozita ugljika pripravljenog od ostataka šećerne repe

The aim of this study was to develop highly porous carbon nanocomposites for detoxification of ochratoxin A (OTA) in broilers. One-day-old chicks were divided into six groups (A to F). Group A was given pure feed. Group B was given 400 μg/kg of OTA contaminated feed, while the rest of the groups were fed on 400 μg/ kg of OTA contaminated feed plus a different level of the adsorbent. The clinical signs of the positive control (group B) such as depression, diarrhea, increased water intake, low body weight, a high degree of genotoxicity, and swollen and hemorrhagic kidneys and liver, were compared with the other groups. In group B chicks, the serum ALT (alanine transferase), ALP (alkaline phosphatase), creatinine and urea levels were significantly higher, while albumin, globulin and total proteins levels were significantly lower than in negative control group A. The adsorbent treated groups showed almost normal clinical signs. Group C and D were affected to some extent, however, groups E and F showed undamaged DNA, normal behavior and blood biochemistry, and well- maintained histological structure, like that of the negative control group.Cilj je ovoga istraživanja bio razviti visokoporozne nanokompozite ugljika za detoksifikaciju ohratoksina A (OTA) u brojlera. Jednodnevni pilići podijeljeni su u šest skupina (A do F). Skupina A hranjena je čistom hranom. Skupini B davana je hrana kojoj je dodano 400 μg/kg OTA-e, dok su preostale skupine hranjene hranom kojoj je uz 400 μg/kg OTA-e dodane različite razine adsorbensa. Klinički znakovi kod pozitivne kontrole (skupina B), poput depresije, proljeva, povećanog unosa vode, niske tjelesne mase, visoke genotoksičnosti, natečenih i krvavih bubrega i jetre, uspoređeni su s ostalim skupinama. Skupine tretirane adsorbensima pokazale su gotovo normalne kliničke znakove. Skupine C i D do neke su mjere zahvaćene, dok su skupine E i F pokazale neoštećenu DNA, normalno ponašanje, normalne biokemijske krvne pokazatelje i dobro održanu histološku strukturu kao i brojleri u negativnoj kontrolnoj skupini

BioMatriX: Sequence analysis, structure visualization, phylogenetics and linkage analysis workbench

The BioMatriX (Build Mine Xplore) is a bioinformatics work bench (http://www.bmx-biomatrix.blogspot.com) developed for biological science community to augment scientific research regarding genomics, proteomics, phylogenetics and linkage analysis in one platform. BioMatriX offers multi-functional services to perform specific tasks like DNA/RNA/Protein sequence analysis with graphical representations, sequence editing, sequence alignment, restriction enzyme mapping, protein structure visualization, mutation and structure superimposition programs along with phylogenetics tree construction supporting dendrograms, neighbor joining and unweighted pair group method with arithmetic mean (UPGMA) programs. Genomic studies like linkage programs are also implemented. Special emphasis has been paid to integrate all the resources in one software so that the researcher does not have to install numerous pieces of software to analyze his data.Keywords: Bioinformatics, linkage, visualizer, alignment, superimposition, phylogenetic

Potential application of Conyza canadensis (L) Cronquist in the management of diabetes: In vitro and in vivo evaluation

Purpose: To investigate the antihyperglycemic activity of Conyza canadensis via α-glucosidase inhibition in alloxan-induced diabetic mice.Methods: In vitro antidiabetic activity was investigated using α-glucosidase inhibition assay with acarbose (62.5, 125, 500 and 1000 μg/ml) as the standard drug. Conyza canadensis crude extract (Cc.Cr) in doses of 10, 30, 100 and 300 mg/kg were administered daily as a single dose to alloxaninduced (200 mg/kg) diabetic mice (Balb/c), and its effect on fasting blood glucose levels and body weight were evaluated for 15 consecutive days; oral glucose tolerance test was conducted. Metformin (500 mg/kg) was used as a standard antidiabetic drug for comparison. Acute toxicity of Cc.Cr was also evaluated at doses of 3 and 5 g/kg.Results: Conyza canadensis crude extract (Cc.Cr) exhibited strong enzyme inhibition at concentrations (μg/ml) of 1000 (74.78 ± 0.92), 500 (65.11 ± 0.07), 250 (57.55 ± 0.41), 125 (51.55 ± 0.67) and 62.5 ( 44.00 ± 0.57), with a median inhibitory concentration (IC50) of 107 μg/ml. Cc.Cr at all test doses (10 - 300 mg / kg) reduced fasting blood glucose levels in alloxan (200 mg/kg) - induced diabetic mice on days 5, 10 and 15 compared to the diabetic control group (p < 0. 001). These effects were similar to those caused by the standard antidiabetic drug, metformin. Cc.Cr at all test doses also increased body weight of treated animals. The extract (300 mg/kg) significantly improved tolerance of oral glucose overload in mice, like metformin. The extract did not cause any mortality up to the maximum dose of 5 g/kg.Conclusion: The results reveal that Conyza canadensis possesses potent secondary metabolites which can cause inhibition of α-glucosidase. Moreover, the plant extract has the ability to reduce blood glucose level in diabetic animals and significantly improves oral glucose overload tolerance.Keywords: Conyza canadensis, α-Glucosidase, Blood glucose, Alloxan, Diabetes, Glucose toleranc

Green Synthesis of Silver Nanoparticles by Using Ziziphus nummularia

Silver nanoparticles of Ziziphus nummularia leaves extract were synthesized and were characterized by UV-Visible spectrophotometry, particle size analyzer, X-ray diffraction (XRD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR), SEM, TGA, and EDX. The XRD pattern reveals the FCC structure of Ag nanoparticles. FTIR spectra confirmed the presence of Ag-O bonding. UV-Visible spectroscopy results confirmed the existence of Ag because of the particular peak in the region of 400–430. The SEM analysis confirmed spherical and uniform Ag nanoparticles with diameter ranging from 30 nm to 85 nm. The EDX analysis revealed strong signals in the silver region and confirmed the formation of silver nanoparticles. The antioxidant potential and antifungal and antimicrobial potential of the leaf extract and silver nanoparticles were also determined. The antioxidant property was determined using DPPH assay. The antibacterial, antifungal, and antioxidant properties were better for the silver nanoparticles than the aqueous leaf extract. The minimum inhibitory concentration (MIC), minimum bactericidal (MBC), and minimum fungicidal concentration (MFC) of plant extract and prepared silver nanoparticles were also tested. The hair growth properties of plant extracts and their respective nanoparticles were observed and good results were noted for nanoparticles as compared to the leaf extract

Impact of Oppressors on Truthfulness: A Case Study on University of Karachi – Students (Under-Graduate & Graduate)

Under this truth model and research study, the truth is defined as a central fold, which is communicated of its surroundings. Truth is always there available to every person for being revealed but each type of personality is distracted, distressed, dominated or oppressed with an oppressor who is a hurdle in prevalence of truth to each personality. It might be a voice, noise, a physical barrier or distortion etc..The communication type between each and every elements of the model is extra personal in nature. The truth to any one type whether, through direct or indirect interaction. Therefore, the model responds for two-way communication process where, each entity or element act as sender and as well as receiver in the same discipline.The model and research study will further help in finding the core hypothesis i.e. to calculate when the ability of truthfulness in under-graduate, post-graduate and graduate standard students come into existence when dealing with various oppressive conditions and policies i.e. being unaware with the truth, and reacted when dealt with the situation of known about the truth, furthermore; what sources are acquired for prevalence of truth. Secondly, the inheritance element in the process of discovering truth from ancestral roots and the frequency of parent child interaction in investigating of disturbing conditions and matter. How both the ends respond i.e. positively or negatively? The truth model will also be assisting in understanding the scenarios of untruthfulness (social interaction) when opposite reactions insist students to act differently to prescribed criteria and standards. Various studies show that untruthfulness occur due to in hunger and starvation. Further, truthfulness is the adverse situation in anger or aggression (need to be checked). Some other factors such as social disorder, neglected by superior authorities (teachers or maestros) also result in provoking truthfulness in the students. The model will be quite helpful in checking of such disorders of truthfulness. Keywords: Two-way Communication process, Disorders of truthfulness, Hunger and Starvation DOI: 10.7176/JESD/10-6-14 Publication date:March 31st 201

Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities

Alzheimer’s disease (AD) is characterized by cognitive inability manifested due to the accumulation of β-amyloid, formation of hyper phosphorylated neurofibrillary tangles, and a malfunctioned cholinergic system. The degeneration integrity of the neuronal network can appear long after the onset of the disease. Nanotechnology-based interventions have opened an exciting area via theranostics of AD in terms of tailored nanomedicine, which are able to target and deliver drugs across the blood–brain barrier (BBB). The exciting interface existing between medicinal plants and nanotechnology is an emerging marvel in medicine, which has delivered promising results in the treatment of AD. In order to assess the potential applications of the medicinal plants, their derived components, and various nanomedicinal approaches, a review of literature was deemed as necessary. In the present review, numerous phytochemicals and various feats in nanomedicine for the treatment of AD have been discussed mechanistically for the first time. Furthermore, recent trends in nanotechnology such as green synthesis of metal nanoparticles with reference to the treatment of AD have been elaborated. Foreseeing the recent progress, we hope that the interface of medicinal plants and nanotechnology will lead to highly effective theranostic strategies for the treatment of AD in the near future

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

The Physics of the B Factories

This work is on the Physics of the B Factories. Part A of this book contains a brief description of the SLAC and KEK B Factories as well as their detectors, BaBar and Belle, and data taking related issues. Part B discusses tools and methods used by the experiments in order to obtain results. The results themselves can be found in Part C